COX

COX

The enzyme cyclooxygenase (COX), also referred to as prostaglandin-endoperoxide synthase (PTGS), is in charge of producing the vital biological mediators known as prostanoids, such as prostaglandins, prostacyclin, and thromboxane. Pain and inflammation symptoms can be reduced by pharmacologically inhibiting COX. The general public has had access to cyclooxygenase activity-inhibiting medications for about 100 years, including aspirin. The two cyclooxygenase isoforms, COX-1 and COX-2, have been identified. The COX-1 enzyme is frequently produced constitutively (i.e., in the gastric mucosa), whereas the COX-2 enzyme is induced (i.e., at sites of inflammation). Aspirin and ibuprofen are examples of NSAIDs that work by inhibiting COX to produce their desired effects. The non-steroidal anti-inflammatory drugs (NSAIDs) are the primary COX inhibitors.

COX related products

Structure Cat No. Product Name CAS No. Product Description
V77404 (+/-)-Catechin Gallate-13C3 (Catechin Gallate 13C3) (+/-)-Catechin Gallate-13C3 is a 13C (carbon 13)-labeled (-)-Catechin gallate.
V77593 2-O-Sinapoyl makisterone A 2-O-Sinapoyl makisterone A (compound 2) is a sinapic acid-ecdysterone hybrid and is a selective inhibitor of COX-2.
V33020 Anemarsaponin B 139051-27-7 Anemarsaponin B is a naturally occuring steroidal saponin extracted from the rhizomes of A.
V78015 Anti-inflammatory agent 52 Anti-inflammatory agent 52 (compound 7j) is an orally bioavailable, potent and specific COX-2 inhibitor.
V78016 Anti-inflammatory agent 53 Anti-inflammatory agent 53 (compound 7c) is an orally bioavailable, potent and specific COX-2 inhibitor.
V2894 ATB-346 1226895-20-0 ATB-346, a structural analog of naproxen (one of the NSAIDs-Nonsteroidal anti-inflammatory drugs), is anti-inflammatory agent.
V31157 Byakangelicol 26091-79-2 Byakangelicol, a leukotriol extracted from Angelica dahurica, inhibits interleukin-1β (IL-1β)-induced prostate cancer in A549 cells by inhibiting the expression and activity of cyclooxygenase-2 (COX-2).
V2102 CAY10404 340267-36-9 CAY10404 is novel, and highly selective inhibitor of COX-2 which has been reported to date, with a selectivity index (SI; SI = IC50COX-1/IC50COX-2) of >500,000.
V31341 Chebulagic acid 23094-71-5 Chebulagic acid is a naturally occurring COX-LOX dual inhibitorisolated from the Terminalia chebula Retz.
V78861 COX-1/2-IN-4 COX-1/2-IN-4 is a COX inhibitor (antagonist) with IC50s of 0.239 μM and 0.191 μM for COX-1 enzyme and COX-2 enzyme, respectively.
V79761 COX-1/2-IN-5 COX-1/2-IN-5 (compound 2a) is a dual (bifunctional) inhibitor of COX1/2 (IC50=2.650 μM, 0.958 μM) with anti-cancer activity.
V80073 COX-2-IN-31 COX-2-IN-31 (compound 7b) is an orally bioactive COX/5-LOX dual (bifunctional) inhibitor (antagonist) with IC50 of 60 nM (COX-2) and 0.9 μM (5-LOX).
V78864 COX-2-IN-33 COX-2-IN-33 (compound 5f) is a COX-2 inhibitor (IC50=45.5 nM) and a potential anti-inflammatory agent.
V79472 COX-2-IN-35 COX-2-IN-35 (compound 7) is a selective COX-2 inhibitor (antagonist) with IC50 of 4.37 nM.
V78603 COX-2/15-LOX-IN-2 COX-2/15-LOX-IN-2 is a potent dual COX-2 and 15-LOX inhibitor (antagonist) with IC50s of 0.065 μM and 1.86 μM, respectively.
V78897 COX-2/15-LOX-IN-3 COX-2/15-LOX-IN-3 (compound 5k) is a dual (bifunctional) inhibitor of COX-2/15-LOX with IC50s of 0.075 μM and 1.97 μM respectively.
V79276 COX-2/15-LOX-IN-4 COX-2/15-LOX-IN-4 (compound 5i) is a dual (bifunctional) inhibitor of COX-2/15-LOX with IC50s of 0.075 μM and 1.97 μM, respectively.
V8259 Deracoxib (SC 046; SC 46; SC 59046) 169590-41-4 Deracoxib (SC-046; SC-46; SC-59046) is a novel and potent NSAID and COX-2 inhibitor used to treat osteoarthritis.
V40446 Desmethyl Celecoxib 170569-87-6 Desmethyl Celecoxib (PTPBS) is an demethylated metabolite of Celecoxib (SC58635; YM-177;SC-58635; YM 177; Celebrex; Xilebao) which is cyclooxygenase-2 (COX-2) inhibitor approved asananti-inflammatory agent of the NSAID class.
V19799 Diclofenac 15307-86-5 Diclofenac (formerly GP-45840; Voltarol; Voltaren) is a potent nonsteroidal anti-inflammatory drug (NSAID), acting as a non-selective COX inhibitor with IC50 of 0.5 μg/ml and 0.5 μg/ml for COX-1 and -2 in intact cells, respectively, used to relieve pain and reduce swelling in flammation.
Contact Us Back to top